Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.

Ruefli-Brasse AA, French DM, Dixit VM.

Science. 2003 Nov 28;302(5650):1581-4. Epub 2003 Oct 23.

2.

TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1.

Thome M, Tschopp J.

Trends Immunol. 2003 Aug;24(8):419-24. Review. No abstract available.

PMID:
12909454
3.

NF-kappaB signaling in lymphocytes: a new cast of characters.

Lucas PC, McAllister-Lucas LM, Nunez G.

J Cell Sci. 2004 Jan 1;117(Pt 1):31-9. Review.

4.

Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.

Bunnell SC.

Mol Interv. 2002 Oct;2(6):356-60, 338. Review.

PMID:
14993411
5.

The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.

Lin X, Wang D.

Semin Immunol. 2004 Dec;16(6):429-35. Review.

PMID:
15541657
6.

New roles for Bcl10 in B-cell development and LPS response.

Fischer KD, Tedford K, Wirth T.

Trends Immunol. 2004 Mar;25(3):113-6. Review. No abstract available.

PMID:
15049289
7.

MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.

Afonina IS, Elton L, Carpentier I, Beyaert R.

FEBS J. 2015 Sep;282(17):3286-97. doi: 10.1111/febs.13325. Epub 2015 Jun 10. Review.

8.

Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.

Thome M, Charton JE, Pelzer C, Hailfinger S.

Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a003004. doi: 10.1101/cshperspect.a003004. Epub 2010 Aug 4. Review.

9.

Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.

Fontán L, Melnick A.

Clin Cancer Res. 2013 Dec 15;19(24):6662-8. doi: 10.1158/1078-0432.CCR-12-3869. Epub 2013 Sep 4. Review.

10.

CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.

Thome M.

Nat Rev Immunol. 2004 May;4(5):348-59. Review. No abstract available.

PMID:
15122200
11.
12.

NF-kappaB activation pathways induced by T cell costimulation.

Schmitz ML, Bacher S, Dienz O.

FASEB J. 2003 Dec;17(15):2187-93. Review.

PMID:
14656980
13.

Multifunctional roles for MALT1 in T-cell activation.

Thome M.

Nat Rev Immunol. 2008 Jul;8(7):495-500. doi: 10.1038/nri2338. Review.

PMID:
18575460
14.

The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.

Turvey SE, Durandy A, Fischer A, Fung SY, Geha RS, Gewies A, Giese T, Greil J, Keller B, McKinnon ML, Neven B, Rozmus J, Ruland J, Snow AL, Stepensky P, Warnatz K.

J Allergy Clin Immunol. 2014 Aug;134(2):276-84. doi: 10.1016/j.jaci.2014.06.015. Review.

15.

Regulation of NF-κB signaling by caspases and MALT1 paracaspase.

Staal J, Bekaert T, Beyaert R.

Cell Res. 2011 Jan;21(1):40-54. doi: 10.1038/cr.2010.168. Epub 2010 Nov 30. Review.

16.
17.

Regulation of NF-κB induction by TCR/CD28.

Cheng J, Montecalvo A, Kane LP.

Immunol Res. 2011 Aug;50(2-3):113-7. doi: 10.1007/s12026-011-8216-z. Review.

18.

The Paracaspase MALT1.

Hachmann J, Salvesen GS.

Biochimie. 2016 Mar;122:324-38. doi: 10.1016/j.biochi.2015.09.018. Epub 2015 Sep 16. Review.

19.

From MALT lymphoma to the CBM signalosome: three decades of discovery.

Rosebeck S, Rehman AO, Lucas PC, McAllister-Lucas LM.

Cell Cycle. 2011 Aug 1;10(15):2485-96. Epub 2011 Aug 1. Review.

20.

NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Blonska M, Lin X.

Cell Res. 2011 Jan;21(1):55-70. doi: 10.1038/cr.2010.182. Epub 2010 Dec 28. Review.

Supplemental Content

Support Center